Dr. Bhavin L. Ram, Senior Vascular Surgeon, Yashoda Hospitals, explains how a sudden severe leg pain could mimic heart attack ...
Performed with favorable safety, the diagnostic yield for coronary function testing in patients with ischemia but nonobstructive arteries was found to exceed 90%.
HELSINKI, 12 March 2026 - Aplagon, a clinical stage biotech pioneering a first-in-class treatment for thrombo-inflammatory ...
CHEYENNE – Chronic Limb Threatening Ischemia (CLTI), a severe form of peripheral arterial disease (PAD), often leads to limb ...
Helsinki, Finland Saturday, March 14, 2026, 18:00 Hrs [IST] ...
In the catheterization laboratory, the most consequential decisions are frequently not about whether to treat, but rather about how far to extend treatment. Nowhere is that tension more apparent ...
Rummo has signed an agreement with ASL Napoli 1 for the acquisition of 100 monthly hours of Neuroradiology services, for a total amount of 95,480 euros. The aim of the hospital is to make use ...
Key points A 68-year-old woman presented to the emergency department of a rural hospital in southern Alberta 1 hour after ...
Researchers analyzing millions of safety reports identified a possible link between a popular obesity drug and an increased reporting of “eye stroke,” a condition tied to reduced blood flow to the ...
A subgroup analysis of the VASALIUS-CV trial showed evolocumab significantly cut LDL cholesterol and cardiovascular event risk in people with diabetes but no known atherosclerosis.
Northwestern Medicine investigators have uncovered a missing link behind the harmful effects of autoantibodies linked to ...
In high-risk patients with diabetes but without known atherosclerosis, evolocumab reduced risk for a first major CV event compared with placebo, according to a subgroup analysis of the VESALIUS-CV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results